Status:
COMPLETED
Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification
Lead Sponsor:
Sligo General Hospital
Conditions:
Ocular Inflammation
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Cataract extraction is one of the most common operative procedures performed throughout the world. Conventionally, patients are discharged with postoperative drops of steroids and antibiotics or a com...
Detailed Description
This is a prospective randomized control trial of 80 patients undergoing routine phacoemulsification cataract extraction. The patients were randomly assigned to receive the triamcinolone injection or ...
Eligibility Criteria
Inclusion
- uncomplicated cataract surgery, ability to attend follow appointments at one week and one month
Exclusion
- included premorbid ocular pathology including previous ocular inflammation and glaucoma, previous ocular surgery, history of CMO, diabetes, concurrent use of systemic anti-inflammatories including inhaled or topical therapy, history of systemic inflammation, inability to attend follow up appointments at one week and one month, complicated cataract surgery
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00789971
Start Date
March 1 2007
End Date
April 1 2008
Last Update
November 13 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sligo General Hospital
Sligo, Sligo, Ireland